Outcome Prediction for Estrogen Receptor-Positive Breast Cancer Based on Postneoadjuvant Endocrine Therapy Tumor Characteristics

Ellis et al. (Tue,) studied this question.

www.synapsesocial.com/papers/69d78a7d447a5ff6a2b8aa59 — DOI: https://doi.org/10.1093/jnci/djn309

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Prognostic and predictive factors in breast cancer by immunohistochemical analysis.· 1998 · 2,168 citations
2. MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORS· 1996 · 9,740 citations
3. Residual Ductal Carcinoma In Situ in Patients With Complete Eradication of Invasive Breast Cancer After Neoadjuvant Chemotherapy Does Not Adversely Affect Patient Outcome· 2007 · 306 citations
4. A poor prognosis ER and HER2-negative, nonbasal, breast cancer subtype identified through postneoadjuvant endocrine therapy tumor profiling· 2008 · 4 citations
5. TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation· 2000 · 1,570 citations